Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
The report details the trend, potential and market size of Intraveno(IV) Iron Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Intraveno(IV) Iron Drugsmarket, defines the market attractiveness level of Intraveno(IV) Iron Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Intraveno(IV) Iron Drugs industry, describes the types of Intraveno(IV) Iron Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Intraveno(IV) Iron Drugs market and the development prospects and opportunities of Intraveno(IV) Iron Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Intraveno(IV) Iron Drugs market in Chapter 13.
By Player:
Luitpold Pharmaceuticals
Pharmacosmos
Galenica
Actavis
Sanofi
Allergan
Fresenius Medical Care
AMAG Pharmaceuticals
Vifor Pharma
American Regent
By Type:
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
By End-User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Intraveno(IV) Iron Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Intraveno(IV) Iron Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Intraveno(IV) Iron Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Intraveno(IV) Iron Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Intraveno(IV) Iron Drugs Market Analysis and Outlook to 2022
-
7.1 Global Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.2 United States Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.3 Europe Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.4 China Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.5 Japan Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.6 India Intraveno(IV) Iron Drugs Consumption (2017-2022)
-
7.7 South Korea Intraveno(IV) Iron Drugs Consumption (2017-2022)
8 Region and Country-wise Intraveno(IV) Iron Drugs Market Analysis and Outlook to 2028
-
8.1 Global Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.2 United States Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.4 China Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.6 India Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Intraveno(IV) Iron Drugs Consumption Forecast (2022-2028)
9 Global Intraveno(IV) Iron Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Intraveno(IV) Iron Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Low Molecular Weight Iron Dextran Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ferric Gluconate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Iron Sucrose Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ferric Carboxyl Maltose Consumption and Growth Rate (2017-2022)
-
9.2 Global Intraveno(IV) Iron Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
10 Global Intraveno(IV) Iron Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Low Molecular Weight Iron Dextran Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ferric Gluconate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Iron Sucrose Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ferric Carboxyl Maltose Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Intraveno(IV) Iron Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Intraveno(IV) Iron Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Intraveno(IV) Iron Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Intraveno(IV) Iron Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Intraveno(IV) Iron Drugs Market Competitive Analysis
-
14.1 Luitpold Pharmaceuticals
-
14.1.1 Luitpold Pharmaceuticals Company Details
-
14.1.2 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Product and Service
-
14.2 Pharmacosmos
-
14.2.1 Pharmacosmos Company Details
-
14.2.2 Pharmacosmos Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pharmacosmos Intraveno(IV) Iron Drugs Product and Service
-
14.3 Galenica
-
14.3.1 Galenica Company Details
-
14.3.2 Galenica Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Galenica Intraveno(IV) Iron Drugs Product and Service
-
14.4 Actavis
-
14.4.1 Actavis Company Details
-
14.4.2 Actavis Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Actavis Intraveno(IV) Iron Drugs Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Intraveno(IV) Iron Drugs Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Intraveno(IV) Iron Drugs Product and Service
-
14.7 Fresenius Medical Care
-
14.7.1 Fresenius Medical Care Company Details
-
14.7.2 Fresenius Medical Care Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Fresenius Medical Care Intraveno(IV) Iron Drugs Product and Service
-
14.8 AMAG Pharmaceuticals
-
14.8.1 AMAG Pharmaceuticals Company Details
-
14.8.2 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Product and Service
-
14.9 Vifor Pharma
-
14.9.1 Vifor Pharma Company Details
-
14.9.2 Vifor Pharma Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Vifor Pharma Intraveno(IV) Iron Drugs Product and Service
-
14.10 American Regent
-
14.10.1 American Regent Company Details
-
14.10.2 American Regent Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 American Regent Intraveno(IV) Iron Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Intraveno(IV) Iron Drugs
-
Figure Intraveno(IV) Iron Drugs Picture
-
Table Global Intraveno(IV) Iron Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intraveno(IV) Iron Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Intraveno(IV) Iron Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Intraveno(IV) Iron Drugs Consumption by Country (2017-2022)
-
Figure United States Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Intraveno(IV) Iron Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Intraveno(IV) Iron Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Intraveno(IV) Iron Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Low Molecular Weight Iron Dextran Consumption and Growth Rate (2017-2022)
-
Figure Global Ferric Gluconate Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Sucrose Consumption and Growth Rate (2017-2022)
-
Figure Global Ferric Carboxyl Maltose Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Low Molecular Weight Iron Dextran Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ferric Gluconate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iron Sucrose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ferric Carboxyl Maltose Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Intraveno(IV) Iron Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Intraveno(IV) Iron Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Luitpold Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Product and Service
-
Table Pharmacosmos (Foundation Year, Company Profile and etc.)
-
Table Pharmacosmos Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmacosmos Intraveno(IV) Iron Drugs Product and Service
-
Table Galenica (Foundation Year, Company Profile and etc.)
-
Table Galenica Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galenica Intraveno(IV) Iron Drugs Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Intraveno(IV) Iron Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Intraveno(IV) Iron Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Intraveno(IV) Iron Drugs Product and Service
-
Table Fresenius Medical Care (Foundation Year, Company Profile and etc.)
-
Table Fresenius Medical Care Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Medical Care Intraveno(IV) Iron Drugs Product and Service
-
Table AMAG Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Product and Service
-
Table Vifor Pharma (Foundation Year, Company Profile and etc.)
-
Table Vifor Pharma Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vifor Pharma Intraveno(IV) Iron Drugs Product and Service
-
Table American Regent (Foundation Year, Company Profile and etc.)
-
Table American Regent Intraveno(IV) Iron Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table American Regent Intraveno(IV) Iron Drugs Product and Service
-
